John Maraganore, Chief Executive Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 69,530 shares at $132.81 ($9.2M) on 2020-02-20, disclosed to the SEC on 2020-02-21.
Seasonal sale ($9.2M) by Chief Executive Officer — this insider has traded ALNY in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $128.62 | 2,672 | $344K | 3.7% |
| 2 | $128.62 | 2,672 | $344K | 3.7% |
| 3 | $129.33 | 1,586 | $205K | 2.2% |
| 4 | $129.33 | 1,586 | $205K | 2.2% |
| 5 | $131.07 | 5,053 | $662K | 7.2% |
| 6 | $131.07 | 5,053 |
| $662K |
| 7.2% |
| 7 | $131.61 | 6,887 | $906K | 9.9% |
| 8 | $131.61 | 6,887 | $906K | 9.9% |
| 9 | $132.81 | 18,065 | $2.4M | 26.2% |
| 10 | $132.81 | 18,065 | $2.4M | 26.2% |
| 11 | $133.42 | 502 | $67K | 0.7% |
| 12 | $133.42 | 502 | $67K | 0.7% |
| Total | $131.85 avg | 69,530 | $9.2M | 100% |
| Filing → |
| ALNY | SELL | 2021-05-17 | $8.9M | — | Filing → |
| ALNY | SELL | 2021-02-26 | $9.4M | — | Filing → |
| ALNY | SELL | 2020-11-20 | $8.6M | — | Filing → |